Detalles de la búsqueda
1.
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases.
Br J Cancer
; 2024 May 14.
Artículo
Inglés
| MEDLINE | ID: mdl-38745088
2.
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab.
Liver Int
; 44(5): 1108-1125, 2024 May.
Artículo
Inglés
| MEDLINE | ID: mdl-38517286
3.
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
Lancet Oncol
; 24(12): 1411-1422, 2023 Dec.
Artículo
Inglés
| MEDLINE | ID: mdl-37951222
4.
Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab.
Oncology
; 101(5): 283-291, 2023.
Artículo
Inglés
| MEDLINE | ID: mdl-36657420
5.
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data.
Liver Int
; 43(8): 1803-1812, 2023 08.
Artículo
Inglés
| MEDLINE | ID: mdl-37452505
6.
The beneficial impact of metabolic dysfunction-associated fatty liver disease on lenvatinib treatment in patients with non-viral hepatocellular carcinoma.
Hepatol Res
; 53(2): 104-115, 2023 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-36149726
7.
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study.
Int J Cancer
; 151(8): 1310-1320, 2022 10 15.
Artículo
Inglés
| MEDLINE | ID: mdl-35723131
8.
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib.
Hepatol Res
; 52(12): 1050-1059, 2022 Dec.
Artículo
Inglés
| MEDLINE | ID: mdl-35960789
9.
Prognostic implication of serum AFP in patients with hepatocellular carcinoma treated with regorafenib.
Future Oncol
; 18(27): 3021-3030, 2022 Sep.
Artículo
Inglés
| MEDLINE | ID: mdl-35903991
10.
Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients.
Oncology
; 99(5): 292-299, 2021.
Artículo
Inglés
| MEDLINE | ID: mdl-33626532
11.
Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis.
Liver Int
; 41(6): 1389-1397, 2021 06.
Artículo
Inglés
| MEDLINE | ID: mdl-33547848
12.
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib.
Liver Int
; 41(12): 2997-3008, 2021 12.
Artículo
Inglés
| MEDLINE | ID: mdl-34250737
13.
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy.
Acta Oncol
; 60(10): 1317-1324, 2021 Oct.
Artículo
Inglés
| MEDLINE | ID: mdl-34282710
14.
Lenvatinib versus Sorafenib as first-line treatment in hepatocellular carcinoma: A multi-institutional matched case-control study.
Hepatol Res
; 51(12): 1229-1241, 2021 Dec.
Artículo
Inglés
| MEDLINE | ID: mdl-34591334
15.
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib.
Hepatol Res
; 51(7): 796-802, 2021 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-34005839
16.
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib.
HPB (Oxford)
; 23(6): 915-920, 2021 06.
Artículo
Inglés
| MEDLINE | ID: mdl-33191108
17.
The oncologic burden of residual disease in incidental gallbladder cancer: An elastic net regression model to profile high-risk features.
Eur J Surg Oncol
; 50(7): 108397, 2024 May 25.
Artículo
Inglés
| MEDLINE | ID: mdl-38815335
18.
Treatment options for advanced hepatocellular carcinoma: the potential of biologics.
Expert Opin Biol Ther
; : 1-16, 2024 Jun 24.
Artículo
Inglés
| MEDLINE | ID: mdl-38913107
19.
Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab.
Target Oncol
; 19(2): 223-235, 2024 Mar.
Artículo
Inglés
| MEDLINE | ID: mdl-38345693
20.
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art.
Expert Rev Gastroenterol Hepatol
; 18(4-5): 141-146, 2024.
Artículo
Inglés
| MEDLINE | ID: mdl-38584510